Lipid profiling reveals galactosylceramide increasing in plasma of atherosclerotic stroke patients by online 2D LC QToF-MS (#47)
Atherosclerosis
was a chronic inflammatory disease with activation of both innate and adaptive
immunity. Lipids, especially galactosylceramides were recognized as antigens
and stimulator of natural killer T (NKT) cells and produced cytokines release. In this work,
we established a novel online normal- and reversed-phase two dimensional (2D)
liquid chromatography (LC) quadrupole time-of-flight mass spectrometry
(QToF-MS) method for lipidomic analysis. This method was applied to identify
the lipid products in plasma and making its merits in quality and quantity of
the detection of lipids. The differences of lipids metabolism products in human
plasma between carotid atherosclerosis patients and control subjects were
identified in details. 518 endogenous lipid species from 17 classes were
determined in human plasma. And we successfully achieved chromatographic
separation of galactosylceramides (GalC) and glucosylceramides (GluC), which are
isomers and have the same molecular weight. Only the levels of GalC in
atherosclerosis patients were significantly increasing, rather than GluC,
compared with the controls (controls vs. patients: the ratio was 1.5-2.8 fold
increasing, P<0.05). The increasing levels of GalC in atherosclerosis groups were
revealed that immune responses were important of atherosclerosis exiting and
progression. It would be helpful to the well understanding atherosclerosis and
further investigation.